Selective Inhibitors of Pancreatic Cholesterol Esterase

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$70,342.00
Award Year:
2001
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Agency Tracking Number:
1R43DK058440-01A1
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
ALBUQUERQUE AVIAN EXOTIC
AND SMALL ANIMAL CLINIC, P.C., 8414 4TH ST NW, ALBUQUERQUE, NM, 87114
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
JOHN HEIDRICH
() -
Business Contact:
(505) 897-8200
LCONTOS@UNM.EDU
Research Institution:
n/a
Abstract
DESCRIPTION (Scanned from the Applicant's Abstract): The specific aim of this esterase (CE) inhibitor in an acute cholesterol absorption assay. Hamsters will be gavage fed 3H-labeled cholesterol with CE-inhibitor ranging from 20-200 umoles. Twenty-four hours later, hepatic and serum cholesterol absorption will be assayed. Hepatic and serum cholesterol levels will be determined in a subchronic hamster assay. CE-inhibitor from 20-200 umoles will be fed in chow supplemented with 0.2 percent cholesterol and 0.1 percent cholic acid for 4 days. Hepatic and serum cholesterol will be determined. In a third study, toxicity will be determined following a 30 day feeding trial of CE inhibitor. The optimum dose of CE-inhibitor determined in the previous two experiments and 200 umoles will be added to chow supplemented with 1 percent cholesterol and 0.5 percent cholic acid. Clinical chemistry, hepatic and serum cholesterol, urinalysis and histopathology will be obtained.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government